Clinical trial / 2006
Plant-based diet adoption was linked to slower PSA rise in recurrent prostate cancer
In a 6-month pre-post pilot trial, recurrent prostate cancer patients adopted a plant-based diet with stress management. Median daily whole grain intake was 1.7 servings at baseline, 6.9 at 3 months, and 5.0 at 6 months; vegetable intake was 2.8, 5.0, and 4.8 servings, respectively. The rate of PSA rise decreased from the prestudy period (0.059) to 0-3 months (-0.002, P < .01), inversely tracking changes in plant-food consumption.
- Study type
- Before-and-after trial
- Who was studied
- Patients with recurrent prostate cancer
- What was measured
- Intake of plant-based foods and rate of prostate-specific antigen rise
THE PAPER
Adoption of a plant-based diet by patients with recurrent prostate cancer.
Nguyen JY, Major JM, Knott CJ, Freeman KM, Downs TM, Saxe GA. Integr Cancer Ther, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.